Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia

Br J Haematol. 2007 Jun;137(6):490. doi: 10.1111/j.1365-2141.2007.06580.x. Epub 2007 Apr 11.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Cryptococcosis / complications*
  • Cryptococcosis / immunology
  • Dermatomycoses / complications*
  • Dermatomycoses / immunology
  • Facial Dermatoses / complications*
  • Facial Dermatoses / immunology
  • Fatal Outcome
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / therapeutic use*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / microbiology
  • Male
  • Middle Aged
  • Sepsis / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Alemtuzumab